MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • MDS Virtual Congress 2020

    Phenotypic analysis of subjects with homozygous and compound heterozygous PANK2 mutations in a single extended pedigree from the Dominican Republic (DR) PKAN cohort

    F. Middleton, C. Muniz, I. Ojukwu, M. Santana Jimenez, P. Stoeter, R. Ericson, A. Espinoza, C. Bass, P. Roa, S. Baser (Santo Domingo, Dominican Republic)

    Objective: Whole exome sequencing and genotypic screening of homozygous and heterozygous PANK2 mutations in the Dominican Republic. Background: PKAN affects 1 in 1,000,000 people worldwide,…
  • MDS Virtual Congress 2020

    The Dystonia Coalition Natural History Project: An Available Research Resource

    S. Norris, H. Jinnah, L. Wright, G. Kilic-Berkmen, J. Hieshetter, D. Peterson, S. Pirio-Richardson, J. Perlmutter (St. Louis, MO, USA)

    Objective: The purpose of this collaborative, international effort is to provide an available resource containing clinical and video data along with biospecimens for dystonia research.…
  • MDS Virtual Congress 2020

    Comprehensive Screening of Genetic, Genomic, Mitochondrial, and Microbiome Associations with Phenotypic Measures in the Dominican Republic PKAN Cohort

    C. Muniz, S. Baser, C. Bass, R. Ericson, A. Espinoza, I. Ojukwu, A. Brindle, M. Santana Jimenez, F. Middleton (Santo Domingo, Dominican Republic)

    Objective: Establish novel molecular predictors of phenotypic variation using screening of genomic, transcriptomic, mitochondrial, microbiome, and clinical features. Background: Pantothenate Kinase Associated Neurodegeneration (PKAN), also…
  • 2019 International Congress

    Dystonia as a main clinical feature of AAMR with a novel GMPPA mutation:A case report

    SL. Li, H. Wang, L. Wang, Y. Guo, XH. Wan, HP. Li, JY. Shi (Peking, China)

    Objective: To extend the spectrum of clinical phenotype in the alacrima, achalasia and mental retardation syndrome(AAMR) by reporting a case. Background: AAMR is a newly…
  • 2019 International Congress

    Structural network fingerprints for GPI-DBS in dystonia

    G. Gonzalez-Escamilla, M. Muthuraman, M. Reich, N. Koirala, C. Riedel, M. Glaser, F. Lange, G. Deuschl, J. Volkmann, S. Groppa (Mainz, Germany)

    Objective: Here, we investigate whether patients who respond to GPi-DBS present different brain global and local network organization and structural MRI fingerprints as derived from…
  • 2019 International Congress

    Neuromuscular electrical stimulation for the treatment of jaw-closing dystonia

    C. Miller-Patterson, E. Burton (Pittsburgh, PA, USA)

    Objective: To measure whether neuromuscular electrical stimulation (NMES) increases jaw-opening distance and improves quality-of-life in jaw-closing dystonia patients. Background: An index case with progressive supranuclear…
  • 2019 International Congress

    The Dutch Yips Study

    E. van Wensen, HJ. Vd Zaag, BP. Vd Warrenburg (Apeldoorn, Netherlands)

    Objective: To investigate the prevalence of the Yips in a well-defined group of golfers and to determine potential risk factors. Background: The Yips is a…
  • 2019 International Congress

    Non-motor Symptoms in Hyperkinetic Movement Disorders

    H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)

    Objective: To evaluate the frequencies and clinical features of non-motor symptoms in several different hyperkinetic movement disorders and compare them with the healthy age- and…
  • 2019 International Congress

    Different clinical entities of Segawa syndrome within a family

    J. Sarangerel (Ulaanbaatar, Mongolia)

    Objective: We report two cases of mother and daughter, both having different expressions of dystonic movements. Background: One of rare dystonic disorders is Segawa syndrome…
  • 2019 International Congress

    Dystonic storm with a change of stimulation from constant voltage to constant current

    Z. Guduru, T. Yamasaki, J. Guwell, J. Lamm, D. Ginjupally, S. Grupke, C. van Horne (Lexington, KY, USA)

    Objective: Deep brain stimulation (DBS) is a FDA approved treatment for dystonia. Medtronic pulse generator (IPG), constant voltage (CV) stimulation and Boston Scientific generator, constant…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 54
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley